Market Overview:
The global diphtheria, tetanus and acellular pertussis combined vaccine market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The increasing incidence of diphtheria, tetanus and pertussis (DTP) in different parts of the world is one of the major factors driving the growth of this market. Additionally, rising awareness about preventive measures against these diseases is also contributing to the growth of this market. On the basis of type, the global diphtheria, tetanus and acellular pertussis combined vaccine market can be segmented into child and adult vaccines. The child segment dominates this market owing to high prevalence rates for DTP among children across different regions worldwide. However, with increasing awareness about preventive measures against these diseases among adults as well as growing demand for adult vaccines in developed countries is expected to boost growth prospects for this segment over the forecast period. Based on application, government institutions account for majority share in terms revenue generated from sales of diphtheria-tetanus-pertussis (DTP) combination vaccines followed by private sector and other applications respectively . However with increase in number os private players venturing into production & distribution od combination vaccines globally ,the private sector is projected witness highest CAGR over next decade .
Product Definition:
DTaP is a vaccine that protects against three diseases: diphtheria, tetanus and pertussis (whooping cough). Diphtheria, tetanus and pertussis are all serious infections. Diphtheria can cause breathing problems, heart problems, paralysis and death. Tetanus can cause muscle spasms, seizures and death. Pertussis (whooping cough) can cause coughing spells so severe that it can lead to pneumonia, long-term health problems or even death.
Child:
The global Child, it's usage and growth factor in Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine market size was valued at USD 8.5 billion in 2018 and is expected to register a CAGR of XX% over the forecast period. Increasing immunization programs globally coupled with rising awareness regarding the importance of immunization are some factors likely to drive the demand for child vaccines during the forecast period.
Adult:
Adult is the second most used vaccine after Pediatric in Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market. It is also known as Adult Diphtheria, Tetanus and Acellular pertussis (DTAAP) or sometimes adult immunization.
Application Insights:
The government sector accounted for the largest share of more than 50.0% in 2017. The rising number of diphtheria, tetanus and acellular pertussis (DTaP) immunization campaigns in developing countries including China, India and Brazil is expected to drive the global market over the forecast period. In addition, growing awareness about immunization among governments worldwide is further anticipated to propel demand from this segment over the next eight years.
Global combined diphtheria, tetanus.
The private sector includes both healthcare providers such as hospitals & clinics.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to high government spending on immunization coupled with a well-developed healthcare system and infrastructure. Moreover, increasing incidence of whooping cough is further propelling the demand for these vaccines in this region. According to WHO, there were more than 50,000 cases reported globally in 2017.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to rising awareness about diphtheria and tetanus vaccination along with increasing accessions by private players at a domestic level as well as through foreign investments at an international level. Furthermore, growing target population base due to rapid urbanization and improving living standards will drive regional market growth over the forecast period as will rising incidence of pertussis disease especially among infants & children which was recently declared eradicated from North America’s soil thus making it one of its most urgent threats worldwide (The Global Disease Threat Assessment 2018).
Growth Factors:
- Increasing incidence of diphtheria, tetanus and pertussis across the globe
- Growing awareness about the benefits of DTP vaccine among parents and healthcare professionals
- Rising demand for pediatric vaccines due to increasing number of births globally
- Technological advancements in vaccine manufacturing process and growing investments in R&D activities by vaccine manufacturers
- Launch of new DTP vaccines with improved efficacy and safety profiles
Scope Of The Report
Report Attributes
Report Details
Report Title
Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Research Report
By Type
Child, Adult
By Application
Government Institution, Private Sector, Other
By Companies
Sanofi Pasteur, GSK, Wuhan Institution, Sanofi Pasteur
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
223
Number of Tables & Figures
157
Customization Available
Yes, the report can be customized as per your need.
Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Report Segments:
The global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine market is segmented on the basis of:
Types
Child, Adult
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Government Institution, Private Sector, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sanofi Pasteur
- GSK
- Wuhan Institution
- Sanofi Pasteur
Highlights of The Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Child
- Adult
- By Application:
- Government Institution
- Private Sector
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Diphtheria, tetanus and acellular pertussis (DTaP) vaccine is a combination vaccine that helps protect against diphtheria, tetanus and pertussis (DP), also known as whooping cough. DTaP is given in three doses over six months.
Some of the major companies in the diphtheria, tetanus and acellular pertussis combined vaccine market are Sanofi Pasteur, GSK, Wuhan Institution, Sanofi Pasteur.
The diphtheria, tetanus and acellular pertussis combined vaccine market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Size & Forecast, 2020-2028
4.5.1 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Size and Y-o-Y Growth
4.5.2 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Child
5.2.2 Adult
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Government Institution
6.2.2 Private Sector
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Child
9.6.2 Adult
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Government Institution
9.10.2 Private Sector
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Child
10.6.2 Adult
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Government Institution
10.10.2 Private Sector
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Child
11.6.2 Adult
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Government Institution
11.10.2 Private Sector
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Child
12.6.2 Adult
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Government Institution
12.10.2 Private Sector
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Child
13.6.2 Adult
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Government Institution
13.10.2 Private Sector
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market: Competitive Dashboard
14.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sanofi Pasteur
14.3.2 GSK
14.3.3 Wuhan Institution
14.3.4 Sanofi Pasteur
